Identifying which patients need access to our medicines is an important consideration for patients with unmet needs and key external stakeholders in the healthcare environment. We want to be confident when we secure access for our solutions that we are not leaving behind any patients who would benefit.
As part of this commitment, we are working to ensure these key questions are considered and addressed as we build our clinical studies and develop our medicines:
Have we identified and fully understood the unmet needs seen in the patient populations we are targeting?
Are we capturing these populations who will benefit the most within our clinical studies?